Home> Sessions

S33 Tumor Immunology and Immunotherapy

Updated: 2025-08-14

Chairs

1.jpg

Fan Zusen

2.jpg

Chen Youhai

Invited speakers & reports 

Fan Zusen

Institute of Biophysics, Chinese Academy of Sciences (CAS)

Report: Discovery of new immune cell subpopulations and regulation of immune responses 

Chen Youhai

Shenzhen University of Advanced Technology, Shenzhen Institutes of Advanced Technology, CAS

Report: Cancer immunotherapy and AI-driven drug development 

Yin Zhinan

Jinan University

Report: Gamma delta T cells: A new platform and vector for immune cell therapy 

Chen Yun

Nanjing Medical University

Report: Tumor microenvironment remodeling and immunotherapy 

Li Lei

The First Affiliated Hospital of Xi’an Jiaotong University

Report: Resistance to tumor immunotherapy and targeted drug development 

Wang Zhi

Hospital of Stomatology, Sun Yat-sen University

Report: Oral mucosal immunity and prevention and control of inflammatory diseases 

Liu Longchao

Institute of Microbiology, CAS

Report: Development of tumor immunopotentiating molecules targeting T-cell activation signaling